Aegis Spine, Inc., an innovative subsidiary of L&K BioMed, announces FDA 510(k) clearance of the new AccelFix Expandable Cage System

Aegis Spine, Inc., an innovative subsidiary of L&K BioMed, is proud and eager to announce FDA 510(k) clearance of the new AccelFix Expandable Cage System – a sterile-packaged, all-encompassing family of expandable interbody devices, which was launched this month at NASS 2019 in Chicago, Illinois.

Advertisement

The AccelFix Expandable Cage System includes expandable interbody solutions from TLIF/PLIF cages (AccelFix-XT), an expandable lateral interbody (AccelFix-XL), and a ground-breaking, Anterior-to-Psoas expandable interbody specially contoured to avoid the contralateral nerve root (Accelfix-XTP).

The launch of the new expandable interbody devices will be added to a wide range of spinal product portfolio which includes AccelFix 5.5 Rod Spinal Fixation System which earned a FDA clearance earlier this year.

AccelFix Email Signature Image 2

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.